Table 3.
Clinicopathologic Features of the 10 Patients with Encapsulated Thyroid Carcinomas
| # | Age | Sex | Histology of primary tumor | Tumor size (cm) | Capsular invasion | Vascular invasion | Highest grade carcinoma in LN | ETE | DM | Time to death (years) | Mode of death |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1a | 44 | M | HCC | 7.2 | Extensive | Extensive | PTC, classical | Microscopic | During FU | 5.8 | DM |
| 2 | 75 | F | HCC | 5.0 | Extensive | Extensive | NA | None | During FU | 8.2 | DM |
| 3 | 44 | M | HCC | 4.0 | Focal | Extensive | NA | None | During FU | 8.4 | DM |
| 4 | 70 | M | HCC | 5.5 | Focal | None | NA | None | At presentation | 0.2 | DM |
| 5 | 66 | M | FVPTC | 5.0 | Extensive | Extensive | NA | None | At presentation | 2.9 | DM |
| 6 | 77 | M | PDTC | 4.4 | Focal | Focal | NA | None | At presentation | 4.9 | DM |
| 7 | 74 | F | PDTC | 5 | Extensive | Extensive | NA | GET | At presentation | 4.8 | DM |
| 8 | 61 | M | PDTC | 8.7 | Focal | Extensive | NA | GET | At presentation | 4.2 | DM |
| 9 | 59 | M | PDTC | 5.3 | Extensive | Extensive | NA | Microscopic | At presentation | 2.5 | DM |
| 10 | 51 | F | PDTC | 4.0 | Extensive | Extensive | NA | None | During FU | 8.9 | DM |
a
Patients #1–5 correspond to patients #1–5 in Table 2.
HCC, Hürthle cell carcinoma; GET, gross extension beyond the thyroid.